The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension. 1976

I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki

Plasma renin activity and aldosterone were measured simultaneously in 67 out-patients with essential hypertension. High aldosterone was more often in patients with high renin, and low levels of aldosterone were usual in those with low and normal renin. In order to study the mechanism by which aldosterone and renin acitvity are suppressed in low-renin hypertension, 25 patients (13 normal-renin hypertensives, 10 low-renin patients including 4 non-responders and two DOC excess hypertensives) were investigated as inpatients. Plasma renin activity, aldosterone and cortisol were determined by the following stimualtions with 3 days of sodium restriction and 2 hours of upright posture, angiotensin II infusion (at a dose which increased 20mmHg of diastolic blood pressure), ACTH administration (rapid i.m. injection of 0.25 mg of alpha 1-24 preparation) and potassium infusion (30 meq of potassium i.v.). Responses of aldosterone in normal-renin hypertensives to all stimulations were 3-5 fold increases from bases line values. Low-renin hypertensives except two of four non-responders showed the responses similar to those in normal-renin patients. The responses of two of the non-responders were similar to those in DOC excess hypertensives who showed reduced responses of aldosterone to some of these stimulations. Thus, it seems that low-renin hypertension is a clinical entity caused by a variety of mechanisms, and the mechanism by which low-renin hypertension is induced is not explained by one factor such as an unknown mineralocorticoid.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011187 Posture The position or physical attitude of the body. Postures
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
July 1992, The Journal of clinical endocrinology and metabolism,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
December 1976, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
April 1978, The Journal of clinical endocrinology and metabolism,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
February 1973, Acta endocrinologica,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
June 1980, The Journal of clinical endocrinology and metabolism,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
June 1978, Circulation research,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
June 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
February 1984, Vrachebnoe delo,
I Saito, and T Saruta, and R Nakamura, and J Misumi, and K Kondo, and S Matsuki
August 1975, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!